Allard, Bastien
Devauchelle-Pensec, Valérie
Saraux, Alain
Nowak, Emmanuel
Tison, Alice
Boukhlal, Sara
Guellec, Dewi
Jousse-Joulin, Sandrine
Cornec, Divi
Marhadour, Thierry
Le Pennec, Romain
Salaün, Pierre-Yves
Querellou, Solène https://orcid.org/0000-0002-4525-2696
Funding for this research was provided by:
Bristol-Myers Squibb
Article History
Received: 26 September 2023
Accepted: 1 December 2023
First Online: 14 December 2023
Declarations
:
: This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee by the appropriate ethics committee (CPP Sud-Est II Ref CPP: 2018–33).
: Informed consent was obtained from all individual participants included in the study.
: The authors affirm that human research participants provided informed consent for the publication of the images in Figs. 1, 4, and 5<i>.</i>
: Valerie Devauchelle Speakers Bureau: Abbvie, BMS, Galapagos, Lilly, Novartis, Pfizer, Sanofi, Grant/Research Support from BMS.Alain Saraux Speakers Bureau: Abbvie, BMS, Galapagos, Lilly, Novartis, Nordic, Pfizer, Roche-Chugai, Sanofi, UCB, Grant/Research Support from Abbvie, BMS, Lilly, Novartis.Nowak Emmanuel: None Declared.Sandrine Jousse-Joulin Speakers Bureau: Abbvie, Amgen, Astra Zeneca, BMS, Galapagos, Janssen, Pfizer, UCB, Novartis, MSD, GSK, Sanofi.Thierry Marhadour: Abbvie, Amgen, Chugaï, Lilly, Mylan, Novartis, Pfizer.The other authors have no relevant financial or non-financial interests to disclose.